1-(3-((4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-6-METHOXY-7-QUINAZOLINYL)OXY)PROPYL)-1-.BETA.-D-GLUCOPYRANURONOSYLPYRROLIDINIUM
UNII 4270FV05PH
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-(3-((4-((4-fluoro-2-methyl-1h-indol-5-yl)oxy)-6-methoxy-7-quinazolinyl)oxy)propyl)-1-.beta.-d-glucopyranuronosylpyrrolidinium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4270FV05PH.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1245018-68-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H36FN4O9 JVJSFWHTACVQLH-NEOPOEGOSA-O Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-(3-((4-((4-fluoro-2-methyl-1h-indol-5-yl)oxy)-6-methoxy-7-quinazolinyl)oxy)propyl)-1-.beta.-d-glucopyranuronosylpyrrolidinium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.